C/EBPα mutations in lung cancer
- 31 August 2006
- journal article
- other
- Published by Elsevier in Lung Cancer
- Vol. 53 (2) , 253-254
- https://doi.org/10.1016/j.lungcan.2006.04.011
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Epigenetic Modulation of Tumor Suppressor CCAAT/Enhancer Binding Protein α Activity in Lung CancerJNCI Journal of the National Cancer Institute, 2006
- Respiratory Failure Due to Differentiation Arrest and Expansion of Alveolar Cells following Lung-Specific Loss of the Transcription Factor C/EBPα in MiceMolecular and Cellular Biology, 2006
- CEBPA Mutations in Younger Adults With Acute Myeloid Leukemia and Normal Cytogenetics: Prognostic Relevance and Analysis of Cooperating MutationsJournal of Clinical Oncology, 2004
- Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)Blood, 2002
- Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemiasBlood, 2002
- AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemiaNature Medicine, 2001
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001